tirzepatide fast track for diabetes: on to SURPASS current therapy Competitor Poised to Take on

Reactive oxygen species also contribute to the activation of the NOD-like receptor family pyrin domain containing 3 (NLRP3) inflammasome, which facilitates the maturation and secretion of interleukin-1 (IL-1) and IL-18, further amplifying inflammation (Dominic et al., 2022)

Mitochondria-associated membranes (MAMs): A novel therapeutic target for treating metabolic syndrome

123 MrchKHanevikKRivenesACBdtkerJENssHStubhaugBet al

Compelling outcomes data that demonstrate the value of weight management will be critical for any expansion of access and reimbursement and change in clinical practice

doi: 10.1172/JCI140695 206 Friedmann AngeliJPSchneiderMPronethBTyurinaYYTyurinVAHammondVJet al

Novel GLP-1-based Medications for Type 2 Diabetes and Obesity (Endocrine Reviews)